Skip to contentC
China Pharma Holdings, Inc.
C
CPHIChina Pharma Holdings, Inc. Q1 2014 · 10-Q
Revenue$7.11M$7.11M−13.9% vs Q1 2013 Net Income$50.41K$50.41KN/M vs Q1 2013 EPS Diluted-$0.05-$0.05N/M vs Q1 2013 Gross Profit$2,660,386N/M Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
Operating Cash Flow-$253,410N/M Free Cash Flowderived-$268,616N/M Margins · derivedGross margin37.4%+56.5 pt vs Q1 2013
Operating margin-32.9%+3.5 pt vs Q1 2013
Net margin0.7%+34.8 pt vs Q1 2013
ended Mar 31, 2014 · filed May 15, 2014 · 45 d after period end